FR2160542B1 - - Google Patents

Info

Publication number
FR2160542B1
FR2160542B1 FR7240734A FR7240734A FR2160542B1 FR 2160542 B1 FR2160542 B1 FR 2160542B1 FR 7240734 A FR7240734 A FR 7240734A FR 7240734 A FR7240734 A FR 7240734A FR 2160542 B1 FR2160542 B1 FR 2160542B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7240734A
Other languages
French (fr)
Other versions
FR2160542A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of FR2160542A1 publication Critical patent/FR2160542A1/fr
Application granted granted Critical
Publication of FR2160542B1 publication Critical patent/FR2160542B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Gram-negative bacteria
    • C07K16/1228Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1235Salmonella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Gram-negative bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Gram-negative bacteria
    • C07K16/1228Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Gram-negative bacteria
    • C07K16/1228Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232Escherichia (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7240734A 1971-11-17 1972-11-16 Expired FR2160542B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2157148A DE2157148A1 (de) 1971-11-17 1971-11-17 Immunisierungsmittel, verfahren zur herstellung und seine verwendung

Publications (2)

Publication Number Publication Date
FR2160542A1 FR2160542A1 (enExample) 1973-06-29
FR2160542B1 true FR2160542B1 (enExample) 1976-04-23

Family

ID=5825419

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7240734A Expired FR2160542B1 (enExample) 1971-11-17 1972-11-16

Country Status (10)

Country Link
JP (1) JPS5512002B2 (enExample)
AT (1) AT332539B (enExample)
BE (1) BE791489A (enExample)
CH (1) CH588867A5 (enExample)
DD (1) DD102410A5 (enExample)
DE (1) DE2157148A1 (enExample)
FR (1) FR2160542B1 (enExample)
GB (1) GB1416544A (enExample)
NL (1) NL7215221A (enExample)
SE (1) SE406419B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3516119A1 (de) * 1985-05-04 1986-11-06 Biotest Pharma GmbH, 6000 Frankfurt Polyvalentes hyperimmunglobulin-praeparat
DE10331974A1 (de) * 2003-07-14 2005-02-17 Uni-Klinikum Schleswig-Holstein Campus Kiel Verfahren zur Herstellung und Verwendung antimikrobielle Proteine induzierender Faktoren
RU2683027C2 (ru) * 2012-12-20 2019-03-26 Заклад Бадавчо-Вдроженёвы Осьродка Сальмонельля "Иммуноляб" Сп. З О.О. Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1468630A (fr) * 1963-03-14 1967-02-10 Taisho Pharmaceutical Co Ltd Préparation du lipide alpha purifié à partir de lipide alpha brut dérivé des lipopolysaccharides de bactéries à gram-négatif

Also Published As

Publication number Publication date
AU4902772A (en) 1974-05-23
JPS5512002B2 (enExample) 1980-03-29
AT332539B (de) 1976-10-11
CH588867A5 (enExample) 1977-06-15
FR2160542A1 (enExample) 1973-06-29
SE406419B (sv) 1979-02-12
ATA975872A (de) 1976-01-15
DE2157148A1 (de) 1973-05-24
BE791489A (fr) 1973-05-16
GB1416544A (en) 1975-12-03
NL7215221A (enExample) 1973-05-21
JPS4861621A (enExample) 1973-08-29
DD102410A5 (enExample) 1973-12-12

Similar Documents

Publication Publication Date Title
DK139823C (enExample)
FR2120784A5 (enExample)
FI53354B (enExample)
FR2152660B1 (enExample)
DK139788C (enExample)
JPS5512002B2 (enExample)
DK137081C (enExample)
CS149839B1 (enExample)
DE2102522A1 (enExample)
CS160267B1 (enExample)
CS158961B1 (enExample)
CS158770B1 (enExample)
CS150066B1 (enExample)
CS161612B1 (enExample)
CS149073B1 (enExample)
CS155684B1 (enExample)
DE2102080A1 (enExample)
CS153837B1 (enExample)
CH561729A5 (enExample)
CH570075A5 (enExample)
CH561841A5 (enExample)
CH566811A5 (enExample)
DD98798A2 (enExample)
CH547388A (enExample)
CH574957A5 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse